Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01618864 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea
A NA study, sponsored by Syneron Medical.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT01618864 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 23 participants.
The verdict
NCT01618864, a NA study, has completed, sponsored by Syneron Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is designed to evaluate the efficacy and safety of the Luxe™ device for use in wrinkle and rosacea treatment. Up to 60 subjects will treat their periorbital and cheek areas daily for 4 weeks and then twice a week for an additional 4 weeks. Evaluations of improvement will be conducted at the clinic after enrollment and during the treatment at 1, 2, 4, and 8 weeks after initiation.
Interventions
- DEVICE Luxe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01618864
The ClinicalTrials.gov registry entry for NCT01618864 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Luxe is the first listed.
NCT01618864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01618864 about?
NCT01618864 is a clinical study titled "Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea". This study is designed to evaluate the efficacy and safety of the Luxe™ device for use in wrinkle and rosacea treatment. Up to 60 subjects will treat their periorbital and cheek areas daily for 4 weeks and then twice a week for an additional 4 weeks. Evaluations of improvement will be conducted at ...
What is the current status of trial NCT01618864?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2012-03. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01618864?
The interventions under investigation include: Luxe (DEVICE).
Who is sponsoring clinical trial NCT01618864?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.